Porath-Waller, A., Beirness, D. J., & Smither, D. D. (2021). Exploring the Predictive Validity of Drug Evaluation and Classification Program Evaluations (Report No. DOT HS 812 959). United States. Department of Transportation. National Highway Traffic Safety Administration. https://doi.org/10.21949/1526013
Porath-Waller, Amy, Douglas J. Beirness, and Dereece D. Smither. Exploring the Predictive Validity of Drug Evaluation and Classification Program Evaluations. Report no. DOT HS 812 959. United States. Department of Transportation. National Highway Traffic Safety Administration, 2021. https://doi.org/10.21949/1526013.
Porath-Waller, Amy, et al. Exploring the Predictive Validity of Drug Evaluation and Classification Program Evaluations. United States. Department of Transportation. National Highway Traffic Safety Administration, 2021, Report no. DOT HS 812 959, ROSA P. https://doi.org/10.21949/1526013.
This report seeks to determine which combinations of drug-related signs and symptoms from the Drug Evaluation and Classification (DEC) protocol most efficiently and effectively predict the drug category or combination used by the subject. A sample of 2,261 DEC evaluations conducted on suspected drug-impaired drivers included cases involving specific drug categories and two-drug combinations commonly encountered by DREs. This study also examined how effectively the set of drug-related measures from the DEC procedure could distinguish drug-positive from drug-negative cases for two common drug categories (cannabis and CNS depressants) and the relative importance of clinical, behavioral and observational measures in predicting drug categories responsible for impairment. Thirteen drug-related indicators were found to significantly contribute to the prediction of drug category; 12 indicators contributed significantly to the prediction of drug combinations.
Porath-Waller, A., Beirness, D. J., & Smither, D. D. (2021). Exploring the Predictive Validity of Drug Evaluation and Classification Program Evaluations (Report No. DOT HS 812 959). United States. Department of Transportation. National Highway Traffic Safety Administration. https://doi.org/10.21949/1526013
Porath-Waller, Amy, Douglas J. Beirness, and Dereece D. Smither. Exploring the Predictive Validity of Drug Evaluation and Classification Program Evaluations. Report no. DOT HS 812 959. United States. Department of Transportation. National Highway Traffic Safety Administration, 2021. https://doi.org/10.21949/1526013.
Porath-Waller, Amy, et al. Exploring the Predictive Validity of Drug Evaluation and Classification Program Evaluations. United States. Department of Transportation. National Highway Traffic Safety Administration, 2021, Report no. DOT HS 812 959, ROSA P. https://doi.org/10.21949/1526013.
ROSA P serves as an archival repository of USDOT-published products including scientific
findings, journal articles, guidelines, recommendations, or other information authored or co-authored by
USDOT or funded partners. As a repository, ROSA P retains documents in their original published format to
ensure public access to scientific information.
Links with this icon indicate that you are leaving a Bureau of Transportation
Statistics (BTS)/National Transportation Library (NTL)
Web-based service.
Thank you for visiting.
You are about to access a non-government link outside of
the U.S. Department of Transportation's National
Transportation Library.
Please note: While links to Web sites outside of DOT are
offered for your convenience, when you exit DOT Web sites,
Federal privacy policy and Section 508 of the Rehabilitation
Act (accessibility requirements) no longer apply. In
addition, DOT does not attest to the accuracy, relevance,
timeliness or completeness of information provided by linked
sites. Linking to a Web site does not constitute an
endorsement by DOT of the sponsors of the site or the
products presented on the site. For more information, please
view DOT's Web site linking policy.
To get back to the page you were previously viewing, click
your Cancel button.